by Editorial Team | Nov 26, 2024 | General News
PhysioMRI transforms medical diagnostics with its innovative portable MRI. A revolutionary advance in the accessibility and accuracy of clinical studies.
Medical technology has taken a historic leap forward. At PhysioMRI we have developed the world’s first portable MRI machine, a breakthrough that promises to democratize access to high-quality medical images, drastically reduce costs, and simplify hospital and clinical processes. This is a true revolution that will forever change the way we understand and use magnetic resonance imaging.
Unprecedented portability
Unlike traditional MRI machines, our units do not require complex electrical installations or specialized cooling systems. This means that PhysioMRI can be installed in virtually any location, from small doctor’s offices to rural clinics or even mobile units.
Its compact and functional design eliminates logistical barriers and opens up a range of possibilities to improve diagnosis in regions with limited resources or rural areas, where it was previously unthinkable to have a quality MRI.
High-quality images, available to everyone
One of the biggest fears with disruptive innovations is the possible sacrifice of quality. But with PhysioMRI, this is not an issue. Our technology delivers medical images of extraordinary sharpness, meeting the highest diagnostic standards in any environment.
“Innovation isn’t just about making something portable; it ‘s about keeping quality intact while reducing costs. PhysioMRI combines the best of cutting-edge technology with the accessibility that today’s healthcare systems demand,” notes Jon Fatelevich, co-founder and CSO of PhysioMRI.
Cost reduction for global access
The cost of MRI scans has historically been a barrier for patients. PhysioMRI radically changes this landscape, offering a price per medical test that is up to 90% cheaper. This not only benefits patients, but also relieves the budgets of hospitals and clinics, which will now be able to offer MRI tests to more people without compromising quality or time of care.
Accessibility is not only measured in terms of cost, but also in time. Thanks to its innovative design, PhysioMRI can significantly reduce installation and start-up times, increasing the operational efficiency of medical centers.
A change in the paradigm of medical imaging
The combination of portability, high image quality and reduced costs is not just a technical breakthrough; it is a complete redefinition of how medical services are delivered around the world. With PhysioMRI, MRI will no longer be a resource reserved for hospitals in large cities. It will now be possible to implement it anywhere on the planet, bridging the gap between advanced technology and those who need it most.
“At PhysioMRI, we are not building machines, we are building a bridge to a more inclusive, efficient and humane healthcare system,” says Jon Fatelevich.
The future is here, and it’s portable
PhysioMRI ‘s potential transcends technology. It is a tool that empowers medical professionals, reduces patient anxiety and makes quality diagnosis available to all.
The launch of the first portable MRI marks a turning point in the history of medicine. PhysioMRI is not just a machine; it is a vision come true, a tool that democratizes access to world-class technology and offers a practical solution to one of the greatest challenges in global health.
The future of medical imaging is here, and it’s more accessible than ever!
Want to be part of the revolution? Find out more about PhysioMRI and how we are transforming the world of medicine.
by Editorial Team | Nov 20, 2024 | General News
Disruptive PhysioMRI Technology captures attention at the event organised by the EIC Tech to Market Venture Building programme
The Venture’s Ignition Day on Health & Medical technologies by the EIC Tech to Market Venture Building programme is one of the most important events in the European innovation and entrepreneurship landscape. This event, which brings together startups and entrepreneurs with investors, companies and industry leaders, provides a unique platform for those initiatives with high potential for impact on the global market. In this context, the participation of PhysioMRI, an innovative company in the field of medical imaging, has been highlighted as a key step in its strategy to attract investors and take its technological solutions to the next level.
Who is PhysioMRI?
PhysioMRI is a medical technology startup that has developed a revolutionary approach to magnetic resonance imaging (MRI) for the diagnosis and monitoring of musculoskeletal and neurological diseases. Through its innovative platform, the company aims to improve diagnostic accuracy and offer more personalized and effective treatments, especially for chronic and complex pathologies. Using advanced artificial intelligence algorithms and functional magnetic resonance imaging techniques, PhysioMRI seeks to transform the way healthcare professionals monitor and treat patients.
PhysioMRI ‘s value proposition focuses on three key pillars: increased diagnostic accuracy, improved treatment process and cost optimization for healthcare systems. This technology not only promises to benefit patients, but also has the potential to revolutionize the medical imaging market, positioning the company as a benchmark in the sector.
Venture’s Ignition Day on Health & Medical technologies by EIC Tech to Market Venture Building programme: A Strategic Opportunity
Venture’s Ignition Day on Health & Medical technologies is an event designed to connect innovative startups with investors and strategic partners. During this event, companies have the opportunity to present their products and services to a panel of investors and experts in various areas, with the aim of raising funding and strengthening their networks.
This only event, is one of the most relevant initiatives within the European innovation ecosystem. Startups selected to participate have the opportunity to present their projects to a select audience of venture capitalists, investment funds, and other key players in the business and technology world.
For PhysioMRI, participating in this meeting was a strategic opportunity to showcase their solution to a global audience and potentially open doors to new sources of funding. As an emerging company in the medical imaging sector, attracting investors is critical in order to scale its operations, continue research and development of its technology, and expand into new markets.
Impact of PhysioMRI participation
PhysioMRI ‘s participation in the Venture’s Ignition Day on Health & Medical technologies was not only an excellent opportunity to present its value proposition to high-level investors, but also allowed the company to receive direct feedback from industry experts and other entrepreneurs. This type of interaction is crucial in the early stages of a startup, as it helps to refine the business proposition, identify potential areas for improvement and strengthen the business strategy.
Through its presentation, PhysioMRI highlighted the innovation of its technology platform, which combines MRI with artificial intelligence algorithms to perform a more detailed and accurate analysis of medical images. The company’s ability to offer more accurate diagnosis and more efficient monitoring of musculoskeletal and neurological conditions was a key point in the proposal that captivated many of the event’s attendees.
In addition, PhysioMRI took the opportunity to highlight the impact that its technology could have on healthcare systems globally. The optimization of costs associated with diagnostics and treatments, as well as the improvement in the efficiency of medical procedures, were factors that stood out in the discussion with the investors present. At a time when healthcare systems are under pressure due to an aging population and increasing demand for more effective treatments, solutions such as PhysioMRI have the potential to transform healthcare.
Attracting investors: A fundamental step
One of the main objectives of PhysioMRI ‘s participation in the seminar organised by the EIC Tech to Market Venture Building programme was to attract investors that could support its long-term expansion and development. Thanks to the visibility gained at the event, the company was able to capture the attention of several investors interested in the healthcare and medical technology sector.
Investors showed particular interest in the scalability of the PhysioMRI solution. The platform’s ability to integrate into hospitals and clinics around the world, as well as the possibility of adapting to different markets, was an aspect that stood out in the discussions. In addition, the growing trend towards the digitalization of healthcare and the use of technologies based on artificial intelligence and data analytics was a key factor for investors to consider PhysioMRI as an attractive opportunity.
For PhysioMRI, securing investment is crucial not only to bring its product to market, but also to continue to develop new functionalities, conduct clinical studies, and comply with regulatory standards governing medical technology. In addition, the financial support will enable the company to improve its infrastructure, hire talent, and carry out marketing campaigns and international expansion.
Looking to the future
Participation in the Venture’s Ignition Day on Health & Medical technologies marks just the beginning of a path that, if followed with the same determination and innovation, could lead PhysioMRI to position itself as a leader in the medical imaging sector. With a unique technology and a solid business model, the startup has the potential to change the way healthcare professionals diagnose and treat patients, and in doing so, contribute significantly to the improvement of healthcare globally.
As the company continues to grow and attract investment, new opportunities for collaboration with other key players in the healthcare ecosystem, such as hospitals, universities and technology companies, are likely to open up, further accelerating its development and expansion.
In summary, PhysioMRI ‘s participation in the event represents an important milestone in its path towards consolidation as one of the most innovative startups in the healthcare sector. These types of events not only provide visibility, but also allow for the establishment of strategic relationships with investors that can play a key role in the future of the company. With the right support, PhysioMRI has all the conditions to become a reference in the field of medical imaging, improving the lives of patients and offering innovative solutions for healthcare systems around the world.
by Editorial Team | Nov 7, 2024 | General News
Selected among thousands of companies, PhysioMRI presents its low-field device at MEDICA, transforming access to diagnostic imaging.
PhysioMRI, selected by the European Union among thousands of MedTech companies, through the European Innovation Council Tech to Market (EIC T2M) coordinator, and thanks to the Entrepreneurship Venture Building program, to present at MEDICA the first portable and accessible MRI device, a “game changer” in diagnostic imaging.
From November 11th to 14th, MEDICA, the world’s leading medical technology event, will be held in Düsseldorf, Germany, attracting the biggest innovators in the healthcare sector to showcase their advances. In its last edition, MEDICA brought together more than 6,000 exhibitors from almost 70 countries, consolidating its position as the largest trade fair in the healthcare sector. The fair is structured in thematic areas that include physiotherapy, medical services, laboratory equipment and, above all, the latest solutions in diagnostic imaging, where PhysioMRI is positioned as a clear leader.
Based in Valencia, PhysioMRI has recently been selected by the European Union from among thousands of medical technology companies for its transformative potential in the market. The company will present the world’s first portable and affordable MRI device, a revolutionary solution that reduces costs by up to 90% compared to traditional machines, thanks to its low magnetic field technology. This breakthrough represents a “game changer” for diagnostic imaging, allowing access to this technology in environments where it is currently not feasible due to budget or infrastructure limitations.
“We are committed to leading the revolution in MRI technology, providing access to unprecedented diagnostic quality at a significantly lower cost,” says Alfonso Rios, CEO of PhysioMRI. “Our goal is to democratize access to magnetic resonance imaging worldwide, a service that should be available in every hospital, clinic and care center, not just in larger facilities or in developed economies.”
PhysioMRI’s technology, unique in its category, opens up a huge potential market, made up of regions and hospitals that today do not have MRI devices due to their high cost. This innovation not only promises to improve medical diagnostics in underserved areas, but also to transform the healthcare system by making it more accessible and effective. In recent trade shows where PhysioMRI has presented its device, investor interest has been high, and the company expects to generate the same impact at MEDICA, demonstrating how its pioneering technology can make a difference in the industry.
With a clear vision for the future, PhysioMRI continues advancing toward its goal of bringing MRI to all levels of the healthcare system, thereby improving the quality of life for millions of people around the world.
by Editorial Team | May 27, 2024 | General News
PhysioMRI successful at the international technology fair VivaTech2024 and Deeptech50 in Paris.
PhysioMRI, the innovative Valencian startup, has achieved resounding success at VivaTech2024, one of the most prestigious technology events in Europe. The fair, which took place from May 22 to 25, brought together more than 150 investors and industry leaders, who had the opportunity to learn first-hand about the latest trends and advances in health technology. Participation in VivaTech2024 and Deeptech50 not only highlights the excellence of PhysioMRI, but also represents an unparalleled opportunity for the Valencian startup to demonstrate its advances and position itself as a leader in the field of health technology globally.
PhysioMRI’s participation in VivaTech2024 was not only a success in terms of visibility, but it was also crucial for the future growth and expansion of the Valencian startup. During the fair, PhysioMRI stood out as one of the top five technology startups in Europe, attracting the attention of numerous investors interested in supporting its growth and expansion by holding a series of strategic meetings and establishing key contacts that will be fundamental to position PhysioMRI in the way. towards a promising future.
Among the most notable meetings include the one held with the CEO of the CIE European Innovation Council, Guillaume Berteloot and its general director, Viorel Peca, also meetings with some of the main investment funds in health technology, as well as with global companies acceptable in Integrate PhysioMRI technology into your medical systems. These contacts have created a strong support network and facilitated initial conversations on investment deals and strategic partnerships. Additionally, the presentations made during the event generated great interest and enthusiasm among attendees, positioning PhysioMRI as an innovative leader in the healthcare field.
The CEO of PhysioMRI, Alfonso Ríos, has expressed his satisfaction with the results obtained during the event. “VivaTech2024 has been an exceptional platform for PhysioMRI. We have had the opportunity to present our revolutionary wearable MRI technology to a global audience of investors, healthcare professionals and industry leaders. The interest and reception we have received exceeds our expectations. expectations and confirm the enormous potential of our innovation,” commented Alfonso Ríos.
PhysioMRI now looks forward to continue building on the momentum generated at VivaTech2024, further strengthening its network of contacts and securing new opportunities for growth and collaboration.
BACK TO NEWS
(more…)
by Editorial Team | Apr 25, 2024 | General News
The European Innovation Council has acknowledged PhysioMRI as one of the five most outstanding technological projects in the European Union for its technology, which represents a significant advancement in the field of medicine, offering an innovative and accessible solution for medical diagnosis. PhysioMRI’s innovation, the world’s first portable magnetic resonance imaging machine, stands out in the European medical technology scene.
PhysioMRI, the world’s first portable magnetic resonance imaging machine, has been selected as one of the five most important technological projects in the European Union, as determined by the European Innovation Council (EIC), the European Commission’s program designed to support and drive innovation and cutting-edge research in Europe, to which this technology has captured the attention of health experts from the European Union.
PhysioMRI is not just a magnetic resonance imaging machine; it is a promise of accessibility and efficiency in medical diagnosis. With a portable design and a structure 20 times more economical than traditional machines, this technology challenges the spatial and economic limitations that previously prevented widespread access to magnetic resonance imaging.
The prestige of PhysioMRI has been recognized by the European Commission, which has invited it to participate in VivaTech2024 and Deeptech50 in Paris, two prominent events on the European technology calendar that will take place from May 22nd to 25th in Paris, France, and will bring together over 100 investors to hear presentations from 50 technology startups from across Europe, showcasing the latest trends and studies in the field of health. These invitations as one of the continent’s top five technological projects underscore the impact and potential of PhysioMRI in the healthcare industry.
Alfonso Ríos, CEO of the Valencia-based startup, expressed his pride in PhysioMRI’s recognition as one of Europe’s top technological projects. “It is an honor and a privilege for us at PhysioMRI to be recognized as one of the top five technological projects in Europe. This recognition is a testament to the hard work and dedication of our team in Valencia. We are committed to revolutionizing the field of medicine with our innovative portable magnetic resonance imaging technology and are excited to share our vision at events like VivaTech2024 and Deeptech50, where we hope to connect with investors, industry leaders, and healthcare professionals from around the world.”
BACK TO NEWS
(more…)
by Editorial Team | Mar 11, 2024 | Investors
The basketball world champion and Euroleague player with Valencia Basket, Víctor Claver, has entered as an investor in PhysioMRI, the startup that has created the world’s first portable magnetic resonance device.
The former NBA player joins a list of stars from the world of sports such as Luis Scola or Fernando San Emeterio who have seen a good business opportunity to invest in the field of health linked to sports. “PhysioMRI is a great project that meets the needs of sports clubs for the rapid diagnosis of injuries, and will also allow them to reduce waiting lists in hospitals around the world. Finally, for me trust is important and in this project I I will meet with friends from the world of basketball like San Emeterio and Luis Scola who are also aware of their value in the world in which we operate,” explains Víctor Claver, player for Valencia Basket and the Spanish national team.
For his part, Luis Scola has applauded the entry of the Valencian athlete as an investor in PhysioMRI, in a project that “will have a very positive impact on society and people’s health since it will make magnetic resonance diagnosis available.” . “. of all the world.” Athletes know MRI technology perfectly, as they have used this technique on many occasions but have always had to go to a hospital. With the portable PhysioMRI solution, these machines are 30 times cheaper than the current ones and will be able to have a presence in the medical departments of clubs, physiotherapy clinics or small hospital centers, something that until now was totally impossible. It will revolutionize MRI technology as it is known to date.
Explains Jon Fatelevich, co-founder of the Spanish startup PhysioMRI. A fact as revolutionary as the possibility of democratizing healthcare costs by reducing MRI diagnoses has attracted attention in the sector. The tests carried out in recent weeks show that it can be diagnosed for a price 30 times lower than the current price, and the endorsement of the Higher Council for Scientific Research (CSIC) gives it that halo of a great revolution in the world of health. The first of the PhysioMRI machines are already manufactured and tested on humans, they are in the certification stage and the company estimates that the prevention stage will begin in the first half of 2023.
BACK TO NEWS
(more…)
by Editorial Team | Mar 10, 2024 | General News
The recent Valencia Summit has witnessed the outstanding participation of PhysioMRI, a leading company in the field of technology applied to medical diagnosis.
The event, which brought together to professionals from various sectors and prominent experts in innovation, served as platform to present and discuss the most recent advances in the field of health and welfare. PhysioMRI, based in Valencia, is proud to have shared its vision and progress in the development of advanced physiotherapy solutions at the Valencia Summit. The company has been at the forefront of the integration of emerging technologies to improve the quality of life of people through more effective and personalized physical therapies.
During his participation in the Valencia Summit, Alfonso Ríos, the manager of PhysioMRI, presented the flagship project, which has captured the attention of the medical community. Participate in Valencia Summit is recognition of the great work and dedication carried out by the entire team of PhysioMRI for all these years.” “We are committed to leading the revolution in MRI technology quality, innovation and excellence in manufacturing “state-of-the-art MRI scanners.” The PhysioMRI project is based on the premise that each patient is unique, and, therefore, Therapies must be tailored to individual needs.
The platform uses algorithms advanced tools to analyze biometric data and create personalized treatment programs that maximize the effectiveness of physical therapy. Alfonso also highlighted the financial support of the CDTI that represents a significant milestone that will enhance the continuous development of the solutions proposed by the company PhysioMRI in the field of medical diagnosis. The approval of aid within the CDTI Neotec program not only validates the vision and PhysioMRI’s commitment to revolutionizing the field of clinical diagnosis through the low-field magnetic resonance technique, but also provides the resources needed to accelerate research and deployment of new functionalities on its platform. This financial support will allow PhysioMRI consolidate its position as a leader in the field of technology applied to diagnosis clinical.
BACK TO NEWS
(more…)
by Editorial Team | Feb 29, 2024 | Investors
The Valencian startup PhysioMRI , which has developed low-field magnetic resonance medical technology, has closed an investment and financing round of 4 million euros . An injection in which it has obtained funds from the Horizon Europe program of the European Union, in addition to the CDTI of the Ministry of Science and Innovation and the Valencian Institute of Finance (IVF), together with previous investors, which include personalities from the world of sport and technology.
Among the investors who are part of the shareholders are recognized basketball figures, such as former NBA players Luis Scola or Víctor Claver . Prestigious businessmen such as Jorge Alonso, Javier Lopezosa, or the Fernández Serosa brothers are also part of it, all of them with experience in the world of sports, the distribution of medical devices and investment in technology, according to the company itself.
PhysioMRI already has a team in operation at the facilities of the Hospital La Fe in Valencia, under a collaboration agreement to improve neural networks and image processing. The company is a leader in the development of low-field MRI devices, priced up to 20 times lower than current devices .
Jon Fatelevich, co-founder of PhysioMRI and leader of the financing and commercialization strategy, explained that “this investment round will allow us to fulfill our ambitious roadmap. In the next 18 months, we will complete CE and FDA certifications and begin manufacturing. of the first generation of our MRI machines.
The company’s intention is to begin selling its product this year, although the first deliveries will be long-term. “The interest from clinics, doctors and even distributors is extraordinary, and in 2023 we will begin the commercialization of our devices, with an estimated delivery date for early 2025,” he explains. This technology has the potential to reduce the cost of testing for patients by 70%.
BACK TO NEWS
(more…)
by Editorial Team | Feb 28, 2024 | General News
The machine is already in the facilities of the Polytechnic University of Valencia (UPV), where it has been tested on humans
The emerging company PhysioMRI has developed, together with the Higher Council for Scientific Research (CSIC), an innovative magnetic resonance device that reduces the cost of current devices by up to 30 times, with the same diagnostic result. The machine is already in the facilities of the Universitat Politècnica de València (UPV), where it has been tested on humans, and the new scanner has shown ” incredible results and offers professionals a high quality image “, as reported the company. It is a device “that has a couple of steps left to be ready for large-scale commercialization ” and become a great advance in medicine worldwide, which will make Spain “a benchmark in the field of research.” of health and advances in biomedical technology,” they indicate.
The low-field machine costs between 20 and 30 times less than current devices , something that, according to sources, “constitutes a great medical advance that will democratize the use of this important diagnostic equipment and will result in better people’s health.” The objective is that MRI diagnosis can reach all parts of the world and the cost of each test does not exceed 50 euros , when the current average is about 300 euros.
The machine has been developed by a research team led by the director of I3M, José María Benlloch, and which also includes Joseba Alonso , a doctor in atomic physics with extensive experience in research projects worldwide. Within the investment support of PhysioMRI there are references from the world of sports, such as the Olympic champion with Argentina Luis Scola or the silver medalist with Spain in the Olympic Games Fernando San Emeterio who, according to sources, know the applications of the machine and its importance for the health of the athlete and of people in general.
BACK TO NEWS
(more…)
by Editorial Team | Feb 28, 2024 | General News
CDTI recognizes the excellence of PhysioMRI: Help from the NEOTEC program to drive innovation in MRI and diagnostics clinical The Center for Industrial Technological Development (CDTI) has announced the granting significant aid to the leading medical technology company, PhysioMRI, through its prestigious NEOTEC program.
This initiative supports innovative and technological projects that have strong potential growth and contribute to the development of the economy and society. The main objective of the CDTI NEOTEC Program is to promote the emergence of new technology companies in Spain, supporting scientific and technological based projects. Selecting PhysioMRI for receiving this help underlines the quality and innovative potential of your proposal in the field of medical diagnosis applied to physiotherapy.
PhysioMRI has demonstrated a continued commitment to excellence in research and development of medical technologies, especially highlighting in the integration of advances in magnetic resonance with applications practices in the diagnosis and monitoring of physiological conditions.
Since its creation PhysioMRI has dedicated all its efforts to developing the technology with a pioneering low-field MRI approach specific for arms and legs, in the Skeletal Muscle area, since presents significant benefits in terms of costs and accessibility without compromise image quality. This approach has allowed the company overcome economic and geographical barriers, meeting the objective of democratize the use of MRI using the latest technology medical as a diagnostic technique.
Among the notable advantages of this device are its size compact, light weight, transportation and installation compared to the conventional MRI scanners used in clinical settings. The capacity of This device can be used in both clinical and residential settings. provides a dynamism impossible with current scanners. The CEO of PhysioMRI, Alfonso Ríos, expressed his enthusiasm for this strategic collaboration with the CDTI, highlighting that this aid will allow the company advance more rapidly in research and development of pioneering technologies that will significantly improve the diagnosis and treatment of various medical conditions.
BACK TO NEWS
(more…)
